Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTERFACE: Combined vs Single BMC Injection for Knee OA
NCT03876795Phase 3Completed
- Sponsor
- Istituto Ortopedico Rizzoli
- Start
- Nov 2019
- Primary completion
- Mar 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous bone marrow cell concentrate in osteoarthritis (OA), sponsored by Istituto Ortopedico Rizzoli. Started Nov 2019; status: completed.
02
Drugs
autologous bone marrow cell concentrate
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03876795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03876795.